𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiphospholipid syndrome associated with immunotherapy for patients with melanoma

✍ Scribed by Luigi Naldi; Francesco Locati; Guido Finazzi; Tiziano Barbui; Tullio Cainelli; Rgen C. Jü Becker; Eva-Bettina Bröcker

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
218 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Active specific immunotherapy with polyv
Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases
✍ Eddy C. Hsueh; Larry Nathanson; Leland J. Foshag; Richard Essner; J. Anne Nizze; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 341 KB 👁 2 views

## BACKGROUND. This study was conducted to document the rate, duration, and type of objective response to active specific immunotherapy with a polyvalent melanoma cell vaccine (PMCV) for patients with in-transit melanoma metastases and to identify any acute or chronic toxic effects of PMCV treatme

Adjuvant immunotherapy for patients with
Adjuvant immunotherapy for patients with melanoma: Are patients with melanoma of the head and neck candidates for this therapy?
✍ Palma M. Shaw; Muthukumaran Sivanandham; Stephanie F. Bernik; Kristen Ditaranto; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Background. Although a wealth of information is available on adjuvant immunotherapy for melanoma, little is known about adjuvant immunotherapy for head and neck melanoma. Interestingly, a few immunotherapy clinical trials report the observation of clinical responses in a subset of patients with head